Arterra Bioscience Balance Sheet Health
Financial Health criteria checks 6/6
Arterra Bioscience has a total shareholder equity of €10.6M and total debt of €343.0K, which brings its debt-to-equity ratio to 3.2%. Its total assets and total liabilities are €12.5M and €1.9M respectively. Arterra Bioscience's EBIT is €1.3M making its interest coverage ratio -5.1. It has cash and short-term investments of €3.4M.
Key information
3.2%
Debt to equity ratio
€342.97k
Debt
| Interest coverage ratio | -5.1x |
| Cash | €3.43m |
| Equity | €10.60m |
| Total liabilities | €1.94m |
| Total assets | €12.54m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: ARBS's short term assets (€7.7M) exceed its short term liabilities (€876.2K).
Long Term Liabilities: ARBS's short term assets (€7.7M) exceed its long term liabilities (€1.1M).
Debt to Equity History and Analysis
Debt Level: ARBS has more cash than its total debt.
Reducing Debt: ARBS's debt to equity ratio has reduced from 39.5% to 3.2% over the past 5 years.
Debt Coverage: ARBS's debt is well covered by operating cash flow (299.1%).
Interest Coverage: ARBS earns more interest than it pays, so coverage of interest payments is not a concern.